Special Issue "Clinical Applications of Microarrays"
A special issue of Microarrays (ISSN 2076-3905).
Deadline for manuscript submissions: closed (30 June 2014)
Prof. Dr. Reinhold Schäfer
Laboratories of Molecular Tumor Pathology and of Functional Genomics, Charité - Universitätsmedizin Berlin, Charitéplatz 1, D-10117 Berlin, Germany
Phone: +49 30 450 536 072
Fax: +49 30 450 536 909
Interests: cancer transcriptomics; oncogenic signal transduction; systems biology & oncology
This special issue summarizes reports on current development and application of microarray technology in the cancer field.
Prof. Dr. Reinhold Schäfer
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. Papers will be published continuously (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are refereed through a peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Microarrays is an international peer-reviewed Open Access quarterly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. For the first couple of issues the Article Processing Charge (APC) will be waived for well-prepared manuscripts. English correction and/or formatting fees of 250 CHF (Swiss Francs) will be charged in certain cases for those articles accepted for publication that require extensive additional formatting and/or English corrections.
- microarray-based analysis of microRNAomes and mRNAomes
- development of secondary assays based on microarray studies for cancer diagnostics
- breast cancer
- lung cancer
- prognostic markers
- work flow from research lab to clinical practice
- reverse phase protein arrays
Microarrays 2014, 3(3), 168-179; doi:10.3390/microarrays3030168
Received: 28 March 2014; in revised form: 4 June 2014 / Accepted: 16 June 2014 / Published: 26 June 2014| PDF Full-text (842 KB) | HTML Full-text | XML Full-text
Microarrays 2013, 2(4), 318-339; doi:10.3390/microarrays2040318
Received: 16 October 2013; in revised form: 19 November 2013 / Accepted: 6 December 2013 / Published: 13 December 2013| PDF Full-text (212 KB) | HTML Full-text | XML Full-text
Review: Improving Pathological Assessment of Breast Cancer by Employing Array-Based Transcriptome Analysis
Microarrays 2013, 2(3), 228-242; doi:10.3390/microarrays2030228
Received: 29 July 2013; in revised form: 17 August 2013 / Accepted: 22 August 2013 / Published: 29 August 2013| Cited by 1 | PDF Full-text (211 KB) | HTML Full-text | XML Full-text
Review: From High-Throughput Microarray-Based Screening to Clinical Application: The Development of a Second Generation Multigene Test for Breast Cancer Prognosis
Microarrays 2013, 2(3), 243-264; doi:10.3390/microarrays2030243
Received: 17 July 2013; in revised form: 12 August 2013 / Accepted: 22 August 2013 / Published: 29 August 2013| PDF Full-text (391 KB) | HTML Full-text | XML Full-text
Last update: 30 December 2013